Global Single-Use Technologies for Biopharmaceuticals Market
Dublin, May 27, 2022 (GLOBE NEWSWIRE) -- The "Single-use Technologies for Biopharmaceuticals: Global Markets" report has been added to ResearchAndMarkets.com's offering.
The report summarizes the market, including a market snapshot and company profiles of key players in the sole-use technologies market. It provides a comprehensive market breakdown with in-depth information about each segment. The overview section of the report describes market trends and dynamics, including drivers, limitations, challenges, and opportunities for the market.
Furthermore, it provides information about market development and future trends useful for organizations, including distributors and exporters. It analyzes critical market players' revenue, product portfolio and recent activities. It further includes strategies adopted by emerging market players with strategic recommendations for new market entrants. Outright information is provided in the report, consisting of historical and current market size, including the market's future potential.
The report will also help inform market players and new entrants about the production and export of goods and services to original equipment manufacturers. The market is segmented based on technology, components, applications, and end user. A geographical market analysis is provided for all the major segments. The report offers a country-level analysis of the market to understand major components better.
208 data tables and 22 additional tables
An overview of the global market for single-use technologies for the biopharmaceutical industry
Estimation of the market size and analyses of global market trends, with data from 2018-2021, with projections of compound annual growth rates (CAGRs) through 2026
Discussion on present and future opportunities and key factors influencing the single-use technologies and bioreactors for pharmaceuticals
Quantification of market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer drugs
Highlights of the market potential for single-use technologies for the biopharmaceutical industry, based on technology, component, application, end user, and region
Description of biologics manufacturing process including upstream and downstream processing and cell harvesting and clarification, and information on single-use technology (SUT)
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and assessment of new developments in the industry
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
Company profiles of major players, including Merck KGaA, Thermo Fisher Scientific Inc. , General Electric Co. , Danaher Corp. , and Sartorius AG
Single-use bioreactor technology has gained considerable importance in biotechnology manufacturing over the years. Several single-use options are available. Scalability is the biggest limitation. The industry's willingness to use single-use bioreactors is influenced by production parameters, product value and development time. It takes more time to complete comparative studies with conventional stainless-steel bioreactors as the rate of implementation is lower than that of acceptance, thus making single-use technology highly desirable in the biopharmaceutical industry.
However, more clarity and understanding regarding the regulatory requirements for single-use bioreactor technology are needed. For example, U. S. FDA regulations for the Cord Blood Registry (CBR) do not explicitly mention single-use bioreactor technology, even though a large number of Investigational New Drug (IND) programs have been approved by the FDA using such systems.
The major factors influencing the growth of the market include increasing demand for personalized medicine, extensive ongoing development efforts, a strong product portfolio, and large application areas for single-use systems. Additionally, lower cost and reduction in the time necessary in the biomanufacturing process when using single-use technology are further driving the growth of the market.
The drug development rate has increased rapidly with the increasing demand for personalized medicines. This has, in turn, increased the demand for single-use technology to avoid the risk of contamination.
A strong product portfolio is further fueling the growth of the market during the forecast period. There are several companies that are offering single-use technologies, such as Thermo Fisher Scientific Inc. , Danaher Corp. , Sartorius AG, General Electric Co. , and PendoTECH LLC. PendoTECH LLC is focused on the development of pressure sensors used to measure static and dynamic pressure of gases and liquids in biopharmaceutical processes.
It also provides a wide range of single-use products such as single-use rotary flowmeters, single-use ultrasonic flowmeters and a compact low-flow ultrasonic flow meter with are usable fluid path.
Key Topics Covered:
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing this Study
What's New in this Update
Scope of Report
Related Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Historical Analysis: the Foundation for Single-Use Technology
Description of Current Market Trends
Raw Material Analysis
Biopharmaceutical Manufacturing Process
Chapter 4 Biologics Process Development Pathway and Application of Single-Use Technologies
Biologics Manufacturing Process
Cell Harvesting and Clarification
Single-Use Technology (Sut)
Process Development Period
Process Development Cost
Chapter 5 Covid-19 Impact on Market
Chapter 6 Market Breakdown by Technology
Wave-Induced Motion Single-Use Bioreactors
Stirred Single-Use Bioreactors
Single-Use Reactors With Vertically Oscillating Perforated Disc
Single-Use Bubble Column
Single-Use Hybrid Reactor
Mixing, Storage and Filling Systems
Tangential Flow Filtration (Tff)
Ion Exchange Chromatography
Hydrophobic Interaction Chromatography
Freeze and Thaw Systems
Flow Measurement Systems
Temperature Measurement Systems
Ph Measurement Systems
Chapter 7 Market Breakdown by Single-Use Component
Other Single-Use Products
Chapter 8 Market Breakdown by Application
Gene Therapy Drugs
Stem Cell and Other Cell Therapies
Chapter 9 Market Breakdown by End-user
Biopharmaceutical Companies and Contract Manufacturers
Labs and Pathology Products
Research Institutes and Academia
Chapter 10 Market Breakdown by Region
Rest of Europe
Rest of Asia-Pacific
Rest of the World (Row)
Middle East and Africa
Chapter 11 Patent Review
Chapter 12 Competitive Analysis and Market Opportunities
Key Supplier and Manufacturer Positioning
Thermo Fisher Scientific Inc.
General Electric Co.
Key Strategy Analysis
Mergers and Acquisitions
New Product Developments and Technologies
Chapter 13 Company Profiles
Aber Instruments Ltd.
Adolf Kunher AG
Applikon Biotechnology B.V.
Biopharma Dynamics Ltd.
Celltainer Biotech Bv
Charter Medical Ltd.
Colder Products Co. (Cpc)
Cole-Parmer Instrument Co. LLC
Colly Flowtech Ab
Compagnie De Saint-Gobain S.A.
Emerson Electric Co.
Esi Technologies Ltd.
General Electric Co.
Holland Applied Technologies Inc.
Malema Engineering Corp.
Meissner Filtration Products Inc.
Omnibrx Biotechnologies Pvt. Ltd.
Parker Hannifin Corp.
Pierre Guerin Sas
Presens Precision Sensing GmbH
Syntegon Technology GmbH
Sentinel Process Systems Inc.
Solida Biotech GmbH
Terumo Cardiovascular Group
Thermo Fisher Scientific Inc.
Trace Analytics GmbH
Vwr International LLC
Watson-Marlow Fluid Technology Group
W.L. Gore & Associates Inc.
Chapter 14 Appendix: Abbreviations
For more information about this report visit https://www.researchandmarkets.com/r/h0ws63
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900